Incidence and Survival Characteristics of Pediatric Ganglioglioma from 2004 to 2018, with Focus on Infratentorial Sites

Overview

Journal Neurooncol Pract

Publisher Oxford University Press

Date 2024 May 13

PMID 38737603

Authors

Yongzhen Chen

Paula Buchanan

Nicole M Brossier

Pournima Navalkele

Affiliations

Soon will be listed here.

Abstract

Background: Ganglioglioma (GG) is a slow-growing glioneuronal neoplasm, most frequently seen in the supratentorial location in older children and associated with epilepsy syndromes. GG is rare in the infratentorial location, hence we embarked upon analyzing the National Cancer Institute's (NCI) Survival, Epidemiology, and End Results (SEER) database to better evaluate GG outcomes by location in comparison to the broader pediatric low-grade glioma (pLGG) population.

Methods: Pediatric patients diagnosed with GG and pLGG from 2004 to 2018 were included in the study. Their demographic, clinical, and survival characteristics were analyzed using SEER*Stat.

Results: This study describes the largest cohort of pediatric GG, including 852 cases from year 2004 to 2018, with focus on infratentorial sites. Patients with brainstem GG or those with subtotally resected disease were identified as having higher risk of death.

Conclusions: Our analysis highlights brainstem GG as a high-risk, poor-prognostic subgroup and elaborates on the incidence and survival characteristic of this lesser-known subgroup.

Citing Articles

Multinodular and Vacuolating Neuronal Tumors: Imaging Features, Diagnosis, and Management Challenges.

Calandrelli R, Mallio C, Bernetti C, Pilato F Diagnostics (Basel). 2025; 15(3).

PMID: 39941264 PMC: 11817111. DOI: 10.3390/diagnostics15030334.

References

Rades D, Zwick L, Leppert J, Bonsanto M, Tronnier V, Dunst J . The role of postoperative radiotherapy for the treatment of gangliogliomas. Cancer. 2009; 116(2):432-42. DOI: 10.1002/cncr.24716. View

Lin X, Huang R, Zhang P, Sun J, Dong G, Huang Y . Low-grade gangliogliomas in adults: A population-based study. Cancer Med. 2020; 10(1):416-423. PMC: 7826489. DOI: 10.1002/cam4.3577. View

Lang F, Epstein F, Ransohoff J, Allen J, Wisoff J, Abbott I . Central nervous system gangliogliomas. Part 2: Clinical outcome. J Neurosurg. 1993; 79(6):867-73. DOI: 10.3171/jns.1993.79.6.0867. View

Gopalakrishnan C, Shrivastava A, Nair S, Radhakrishnan N . Brainstem ganglioglioma in an infant: Case report and review of literature. J Pediatr Neurosci. 2013; 8(1):41-5. PMC: 3680895. DOI: 10.4103/1817-1745.111422. View

Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler O, Schramm J . Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer. 2004; 101(1):146-55. DOI: 10.1002/cncr.20332. View

Compton J, Laack N, Eckel L, Schomas D, Giannini C, Meyer F . Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg. 2012; 117(5):825-30. DOI: 10.3171/2012.7.JNS111260. View

Lagares A, Gomez P, Lobato R, Ricoy J, Ramos A, de la Lama A . Ganglioglioma of the brainstem: report of three cases and review of the literature. Surg Neurol. 2001; 56(5):315-22; discussion 322-4. DOI: 10.1016/s0090-3019(01)00618-8. View

Dudley R, Torok M, Gallegos D, Mulcahy-Levy J, Hoffman L, Liu A . Pediatric low-grade ganglioglioma: epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database. Neurosurgery. 2015; 76(3):313-9. PMC: 4333003. DOI: 10.1227/NEU.0000000000000619. View

Cantor E, Berkovich R, Navalkele P, Brossier N . Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy. Pediatr Blood Cancer. 2023; 70(7):e30296. PMC: 10500853. DOI: 10.1002/pbc.30296. View

10.

Pan C, Chen X, Xu C, Wu W, Zhang P, Wang Y . Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes. J Neurooncol. 2016; 128(3):445-53. DOI: 10.1007/s11060-016-2131-z. View

11.

Philippe L, Maria K, Tariq A, Sofia M, Christine S, Jean-Pierre F . Efficacy of Dabrafenib for three children with brainstem BRAF positive ganglioglioma. J Neurooncol. 2019; 145(1):135-141. DOI: 10.1007/s11060-019-03280-2. View

12.

Ostrom Q, Price M, Ryan K, Edelson J, Neff C, Cioffi G . CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. Neuro Oncol. 2022; 24(Suppl 3):iii1-iii38. PMC: 9447434. DOI: 10.1093/neuonc/noac161. View

13.

Lundar T, Due-Tonnessen B, Fric R, Egge A, Krossnes B, Due-Tonnessen P . Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients. Acta Neurochir (Wien). 2018; 160(6):1207-1214. PMC: 5948304. DOI: 10.1007/s00701-018-3550-8. View

14.

Zaky W, Patil S, Park M, Liu D, Wang W, Wani K . Ganglioglioma in children and young adults: single institution experience and review of the literature. J Neurooncol. 2018; 139(3):739-747. DOI: 10.1007/s11060-018-2921-6. View

15.

Zhang S, Wang X, Liu X, Ju Y, Hui X . Brainstem gangliogliomas: a retrospective series. J Neurosurg. 2013; 118(4):884-8. DOI: 10.3171/2013.1.JNS121323. View

16.

Janjua M, Ivasyk I, Pisapia D, Souweidane M . Ganglioglioma of brain stem and cervicomedullary junction: A 50years review of literature. J Clin Neurosci. 2017; 44:34-46. DOI: 10.1016/j.jocn.2017.06.021. View

17.

Blumcke I, Wiestler O . Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002; 61(7):575-84. DOI: 10.1093/jnen/61.7.575. View

18.

El Khashab M, Gargan L, Margraf L, Koral K, Nejat F, Swift D . Predictors of tumor progression among children with gangliogliomas. Clinical article. J Neurosurg Pediatr. 2009; 3(6):461-6. DOI: 10.3171/2009.2.PEDS0861. View

19.

Im S, Chung C, Cho B, Wang K, Yu I, Song I . Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol. 2002; 59(2):173-83. DOI: 10.1023/a:1019661528350. View

20.

Yust-Katz S, Anderson M, Liu D, Wu J, Yuan Y, Olar A . Clinical and prognostic features of adult patients with gangliogliomas. Neuro Oncol. 2013; 16(3):409-13. PMC: 3922509. DOI: 10.1093/neuonc/not169. View